Saturday, 31 October 2026European Markets

SWORD GROUP, LECTRA, Another 1 Companies Have A High Dividend Yield And Return On Equity In The Technology Sector.

Loading stream...

(vianews) - sword group (swp.pa) is among this list of stock assets with the highest dividend rate and return on equity on the technology sector.

financial asset price forward dividend yield return on equity
sword group (swp.pa) €39.75 4.29% 16.72%
lectra (lss.pa) €30.65 2.02% 7.4%
capgemini (cap.pa) €188.90 1.72% 17.8%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. sword group (swp.pa)

4.29% forward dividend yield and 16.72% return on equity

sword group s.e. provides it and digital transformation services in europe, the united states, the oceania, and asia. the company provides strategic and operational consulting, solution engineering and application development, project ownership support and project management support, infrastructure management and application maintenance for third parties, and resource outsourcing. its products include sword phusion, which capture and manage information in a single, accessible, and reliable form; sword tell, a cad software for watch manufacturers; sword venue, a digital collaborative solution with a toolbox to help plan the events; and sword aequos that helps to create a flexible and customisable data viewing and search experience. the company serves energy, epc, chemical, utilities, and manufacturing sector. sword group s.e. was founded in 2000 and is headquartered in windhof, luxembourg.

earnings per share

as for profitability, sword group has a trailing twelve months eps of €1.71.

pe ratio

sword group has a trailing twelve months price to earnings ratio of 23.25. meaning, the purchaser of the share is investing €23.25 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 16.72%.

moving average

sword group's worth is way above its 50-day moving average of €35.51 and below its 200-day moving average of €40.10.

revenue growth

year-on-year quarterly revenue growth grew by 10.7%, now sitting on 286.37m for the twelve trailing months.

volume

today's last reported volume for sword group is 381 which is 96.44% below its average volume of 10725.

more news about sword group.

2. lectra (lss.pa)

2.02% forward dividend yield and 7.4% return on equity

lectra sa provides industrial intelligence solutions for fashion, automotive, and furniture markets. the company's solutions include software, automated cutting equipment, data, and related services, which enable customers to automate and optimize product design, development, and manufacture of garments, car seats and interiors, airbags, and sofas, as well as to digitalize their processes. it also offers technical maintenance, support, training, and consulting services; and sells consumables and parts. the company operates in europe, the americas, the asia-pacific, and internationally. lectra sa was incorporated in 1973 and is headquartered in paris, france.

earnings per share

as for profitability, lectra has a trailing twelve months eps of €0.91.

pe ratio

lectra has a trailing twelve months price to earnings ratio of 33.68. meaning, the purchaser of the share is investing €33.68 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.4%.

moving average

lectra's value is way higher than its 50-day moving average of €25.95 and above its 200-day moving average of €30.58.

more news about lectra.

3. capgemini (cap.pa)

1.72% forward dividend yield and 17.8% return on equity

capgemini se provides consulting, digital transformation, technology, and engineering services primarily in the americas, europe, the middle east, africa, and the asia-pacific. the company offers strategy and transformation services, including strategy, technology, data science, and creative design to support various clients within the digital economy. it also provides applications and technology services that helps the clients to develop, modernize, extend, and secure their it and digital environment using the latest technologies, as well as offers local technology services in cloud, cybersecurity, quality assurance, testing, and new technology fields. in addition, the company offers business process outsourcing and transactional services, as well as installation and maintenance services for its clients' it infrastructures in data centers or in the cloud. it serves various industries, including consumer goods and retail; energy and utilities; banking, capital markets, and insurance; manufacturing and life sciences; public sector; telecommunications, media, and technology; and services. capgemini se has strategic partnerships with cona services llc to develop digital solutions for the consumer products industry and retail customers; and innoveo inc. to deliver digital transformation solutions to insurance clients across various lines of business. the company was founded in 1967 and is headquartered in paris, france.

earnings per share

as for profitability, capgemini has a trailing twelve months eps of €9.55.

pe ratio

capgemini has a trailing twelve months price to earnings ratio of 19.78. meaning, the purchaser of the share is investing €19.78 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.8%.

more news about capgemini.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com